TMCnet News
Viral Inactivation Market (2017-2025): Analysis by Product, by Application, End-use & Segment - Research and MarketsThe "Viral Inactivation Market, 2014-2025" report has been added to Research and Markets' offering. The global viral inactivation market is anticipated to reach USD 5.1 billion by 2025, growing at a CAGR of 12.5%. Rise in the number of pharmaceutical and biopharmaceutical companies, increase in FDA drug approvals, growth of the life sciences industry, increase in government funding for novel therapies, and drug development are some of the major factors contributing to the growth. Immense growth has been witnessed in the pharmaceutical and biopharmaceutical industry with a steady rise in the number of companies, drug launches, and new drug discoveries. With an increase in the number of diseases worldwide, the need for new & improved drugs and therapies has been witnessed on a global front. Increase in investment by top players in researc and development coupled with the need to find new therapies for the treatment of diseases has contributed to immense growth of pharmaceutical and biopharmaceutical companies, thereby accelerating growth. Companies Mentioned:
Key Topics Covered: Chapter 1 Research Methodology Chapter 2 Executive Summary Chapter 3 Viral inactivation Market Variables, Trends & Scope Chapter 4 Viral Inactivation Market: Product Estimates & Trend Analysis Chapter 5 Viral Inactivation Market: Application Estimates & Trend Analysis Chapter 6 Viral Inactivation Market: End-use Estimates & Trend Analysis Chapter 7 Viral Inactivation Market: Regional Estimates & Trend Analysis, By Product, Application, End-use Chapter 8 Competitive Landscape For more information about this report visit https://www.researchandmarkets.com/research/gkvwqf/viral View source version on businesswire.com: http://www.businesswire.com/news/home/20170925006047/en/ |
